Human ADGRE1/EMR1 HEK293T Stable Cell Line

Introduction

The Human ADGRE1/EMR1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the ADGRE1/EMR1 protein. This stable cell line is derived from HEK293T cells, a human embryonic kidney cell line commonly used in scientific research. The ADGRE1/EMR1 protein, also known as EGF-like module-containing mucin-like hormone receptor 1, is a transmembrane glycoprotein that belongs to the EGF-TM7 family of receptors. It is expressed on the surface of various immune cells, including monocytes, macrophages, and dendritic cells, and has been implicated in inflammatory and immune responses.

Structure of ADGRE1/EMR1 Protein

The ADGRE1/EMR1 protein consists of a large extracellular domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain contains two EGF-like domains and eight mucin-like domains, which are important for protein-protein interactions and ligand binding. The transmembrane domain anchors the protein to the cell membrane, while the cytoplasmic tail contains conserved signaling motifs that are crucial for downstream signaling.

Activity of ADGRE1/EMR1 Protein

The ADGRE1/EMR1 protein has been shown to play a role in various cellular functions, including cell adhesion, migration, and phagocytosis. It is also involved in the regulation of inflammatory responses and has been linked to autoimmune diseases and cancer. The activity of ADGRE1/EMR1 is mediated by its interaction with ligands such as fibrinogen, vitronectin, and the extracellular matrix protein tenascin-C. These interactions can trigger downstream signaling pathways, leading to changes in cell behavior and immune responses.

Application in Flow Cytometry

Flow cytometry is a powerful technique that allows for the analysis of individual cells based on their physical and biochemical properties. The Human ADGRE1/EMR1 HEK293T Stable Cell Line is a valuable tool for flow cytometry experiments, as it provides a consistent and reliable source of cells expressing the ADGRE1/EMR1 protein. These cells can be used to study the expression levels of ADGRE1/EMR1 on different cell types and to investigate its role in cell adhesion, migration, and other cellular functions.

Therapeutic Target

The ADGRE1/EMR1 protein has been identified as a potential therapeutic target for various diseases, including autoimmune disorders and cancer. Studies have shown that blocking the activity of ADGRE1/EMR1 can reduce inflammation and improve symptoms in animal models of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. In cancer, ADGRE1/EMR1 has been found to promote tumor growth and metastasis, making it a promising target for anti-cancer therapies.

Conclusion

The Human ADGRE1/EMR1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the ADGRE1/EMR1 protein. Its consistent expression of ADGRE1/EMR1 makes it an ideal model for flow cytometry experiments, and its potential as a therapeutic target highlights the importance of understanding the role of this protein in various diseases. Further research using this stable cell line may lead to new insights and potential treatments for conditions involving ADGRE1/EMR1 dysregulation.